Barr Highlights Uncertainties On Plan B OTC Approval Timing
This article was originally published in The Tan Sheet
Executive Summary
Barr Labs says it is unclear whether FDA will meet its already delayed PDUFA deadline for a decision on whether to switch the Rx emergency contraceptive Plan B (levonorgestrel) over the counter